| Literature DB >> 34191522 |
Hayden Wilkinson1,2,3, Kristina A Thomsson4, Ana L Rebelo2, Mark Hilliard1, Abhay Pandit2, Pauline M Rudd1, Niclas G Karlsson4,5, Radka Saldova1,2,3.
Abstract
O-Glycosylation changes in misfolded proteins are of particular interest in understanding neurodegenerative conditions such as Parkinson's disease (PD) and incidental Lewy body disease (ILBD). This work outlines optimizations of a microwave-assisted nonreductive release to limit glycan degradation and employs this methodology to analyze O-glycosylation on the human striatum and substantia nigra tissue in PD, ILBD, and healthy controls, working alongside well-established reductive release approaches. A total of 70 O-glycans were identified, with ILBD presenting significantly decreased levels of mannose-core (p = 0.017) and glucuronylated structures (p = 0.039) in the striatum and PD presenting an increase in sialylation (p < 0.001) and a decrease in sulfation (p = 0.001). Significant increases in sialylation (p = 0.038) in PD were also observed in the substantia nigra. This is the first study to profile the whole nigrostriatal O-glycome in healthy, PD, and ILBD tissues, outlining disease biomarkers alongside benefits of employing orthogonal techniques for O-glycan analysis.Entities:
Keywords: O-glycans; Parkinson’s disease (PD); biomarkers; exoglycosidases; incidental Lewy bodies disease (ILBD); liquid chromatography (LC); mass spectrometry (MS); methods; striatum; substantia nigra; β-elimination
Year: 2021 PMID: 34191522 DOI: 10.1021/acs.jproteome.1c00219
Source DB: PubMed Journal: J Proteome Res ISSN: 1535-3893 Impact factor: 4.466